Merck KGaA (OTCMKTS:MKGAF) Shares Up 0.8% – Here’s Why

Merck KGaA (OTCMKTS:MKGAF)’s share price rose 0.8% on Thursday . The stock traded as high as $151.95 and last traded at $150.50. Approximately 171 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 522 shares. The stock had previously closed at $149.25.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded shares of Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Trading Down 0.1 %

The company has a market cap of $19.43 billion, a P/E ratio of 22.08 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The business has a 50 day moving average price of $158.98 and a 200-day moving average price of $172.07.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.